Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.

Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Lee JE, Williams MD, Perrier ND.

Ann Surg Oncol. 2019 May 20. doi: 10.1245/s10434-019-07451-3. [Epub ahead of print]

PMID:
31111352
2.

Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases.

Christakis I, Ng CS, Chen C, Yiin YH, Grubbs EG, Perrier ND, Lee JE, Graham PH.

Surgery. 2019 Mar;165(3):637-643. doi: 10.1016/j.surg.2018.09.004. Epub 2018 Oct 25.

PMID:
30482519
3.

Endoscopic dilatation improves long-term dysphagia following head and neck cancer therapies: a randomized control trial.

Wu PI, Szczesniak MM, Maclean J, Graham PH, Quon H, Choo L, Cook IJ.

Dis Esophagus. 2019 Jun 1;32(6). pii: doy087. doi: 10.1093/dote/doy087.

PMID:
30462194
4.

Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident.

Fisher SB, Cote GJ, Bui-Griffith JH, Lu W, Tang X, Hai T, Fisher KE, Williams MD, Wistuba II, Waguespack SG, Dorman CM, Ludwig MS, Graham PH, Perrier ND, Lee JE, Grubbs EG.

Surgery. 2019 Jan;165(1):58-63. doi: 10.1016/j.surg.2018.08.029. Epub 2018 Nov 2.

PMID:
30392857
5.

Endobronchial brachytherapy in the management of lung malignancies: 20 years of experience in an Australian center.

Knox MC, Bece A, Bucci J, Moses J, Graham PH.

Brachytherapy. 2018 Nov - Dec;17(6):973-980. doi: 10.1016/j.brachy.2018.07.010. Epub 2018 Jul 29.

PMID:
30064904
6.

Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients.

Sagiv O, Kandl TJ, Thakar SD, Thuro BA, Busaidy NL, Cabanillas M, Jimenez C, Dadu R, Graham PH, Debnam JM, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb;35(1):50-52. doi: 10.1097/IOP.0000000000001161.

PMID:
29927883
7.

miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense.

Pajic M, Froio D, Daly S, Doculara L, Millar E, Graham PH, Drury A, Steinmann A, de Bock CE, Boulghourjian A, Zaratzian A, Carroll S, Toohey J, O'Toole SA, Harris AL, Buffa FM, Gee HE, Hollway GE, Molloy TJ.

Cancer Res. 2018 Jan 15;78(2):501-515. doi: 10.1158/0008-5472.CAN-16-3105. Epub 2017 Nov 27.

8.

Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness.

Voss RK, Feng L, Lee JE, Perrier ND, Graham PH, Hyde SM, Nieves-Munoz F, Cabanillas ME, Waguespack SG, Cote GJ, Gagel RF, Grubbs EG.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2807-2813. doi: 10.1210/jc.2017-00317.

9.

Clinical utility of a functional lumen imaging probe in management of dysphagia following head and neck cancer therapies.

Wu PI, Szczesniak MM, Maclean J, Choo L, Quon H, Graham PH, Zhang T, Cook IJ.

Endoscopy. 2017 Sep;49(9):848-854. doi: 10.1055/s-0043-110670. Epub 2017 May 31.

PMID:
28564716
10.

Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma.

Silva-Figueroa AM, Hess KR, Williams MD, Clarke CN, Christakis I, Graham PH, Grubbs EG, Lee JE, Busaidy NL, Perrier ND.

J Am Coll Surg. 2017 Mar 15. pii: S1072-7515(17)30179-5. doi: 10.1016/j.jamcollsurg.2017.01.060. [Epub ahead of print]

PMID:
28427885
11.

Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.

Chang L, Ni J, Beretov J, Wasinger VC, Hao J, Bucci J, Malouf D, Gillatt D, Graham PH, Li Y.

Sci Rep. 2017 Feb 22;7:41834. doi: 10.1038/srep41834.

12.

Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.

Sullivan MC, Graham PH, Alexander EK, Ruan DT, Nehs MA, Gawande AA, Moore FD Jr, Howitt BE, Strickland KC, Krane JF, Barletta JA, Cho NL.

J Am Coll Surg. 2017 Jun;224(6):1021-1027. doi: 10.1016/j.jamcollsurg.2016.12.007. Epub 2016 Dec 23.

PMID:
28017809
13.

All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients.

Long KL, Etzel C, Rich T, Hyde S, Perrier ND, Graham PH, Lee JE, Hu MI, Cote GJ, Gagel R, Grubbs EG.

Fam Cancer. 2017 Apr;16(2):283-289. doi: 10.1007/s10689-016-9948-7.

PMID:
27864651
14.

The evolving roles and controversies of radiotherapy in the treatment of glioblastoma.

Hau E, Shen H, Clark C, Graham PH, Koh ES, L McDonald K.

J Med Radiat Sci. 2016 Jun;63(2):114-23. doi: 10.1002/jmrs.149. Epub 2016 Jan 21. Review.

15.

Endocrine incidentalomas.

Starker LF, Prieto PA, Liles JS, Tran Cao HS, Grubbs EG, Lee JE, Perrier ND, Graham PH.

Curr Probl Surg. 2016 May;53(5):219-46. doi: 10.1067/j.cpsurg.2016.04.001. Epub 2016 May 3. Review. No abstract available.

PMID:
27325542
16.

Videofluoroscopic Swallow Examination Does Not Accurately Detect Cricopharyngeal Radiation Strictures.

Szczesniak MM, Maclean J, O'Hare J, Humbert I, Wu PI, Quon H, Graham PH, Cook IJ.

Otolaryngol Head Neck Surg. 2016 Sep;155(3):462-5. doi: 10.1177/0194599816645270. Epub 2016 May 3.

PMID:
27143709
17.

Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience.

Christakis IA, Potylchansky E, Silva AM, Nates JP, Prieto PA, Graham PH, Grubbs EG, Lee JE, Perrier ND.

Surgery. 2016 Aug;160(2):377-83. doi: 10.1016/j.surg.2016.02.024. Epub 2016 Apr 7.

PMID:
27063343
18.

Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling.

You J, Willcox M, Fitzgerald A, Schiller B, Cozzi PJ, Russell PJ, Walsh BJ, Wasinger VC, Graham PH, Li Y.

Anal Biochem. 2016 Mar 1;496:30-4. doi: 10.1016/j.ab.2015.12.006. Epub 2015 Dec 21.

PMID:
26717899
19.

Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.

Beretov J, Wasinger VC, Millar EK, Schwartz P, Graham PH, Li Y.

PLoS One. 2015 Nov 6;10(11):e0141876. doi: 10.1371/journal.pone.0141876. eCollection 2015.

20.

Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour.

Huang KT, Mikeska T, Li J, Takano EA, Millar EK, Graham PH, Boyle SE, Campbell IG, Speed TP, Dobrovic A, Fox SB.

BMC Cancer. 2015 Oct 9;15:669. doi: 10.1186/s12885-015-1676-0.

21.

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.

Chang L, Graham PH, Ni J, Hao J, Bucci J, Cozzi PJ, Li Y.

Crit Rev Oncol Hematol. 2015 Dec;96(3):507-17. doi: 10.1016/j.critrevonc.2015.07.005. Epub 2015 Jul 18. Review.

PMID:
26253360
22.

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique.

Harris EJ, Mukesh M, Jena R, Baker A, Bartelink H, Brooks C, Dean J, Donovan EM, Collette S, Eagle S, Fenwick JD, Graham PH, Haviland JS, Kirby AM, Mayles H, Mitchell RA, Perry R, Poortmans P, Poynter A, Shentall G, Titley J, Thompson A, Yarnold JR, Coles CE, Evans PM; on behalf of the IMPORT Trials Management Group.

Southampton (UK): NIHR Journals Library; 2014 Nov.

23.

Streamlining variability in hospital charges for standard thyroidectomy: Developing a strategy to decrease waste.

Morris LF, Romero Arenas MA, Cerny J, Berger JS, Borror CM, Ong M, Cayo AK, Graham PH, Grubbs EG, Lee JE, Perrier ND.

Surgery. 2014 Dec;156(6):1441-9; discussion 1449. doi: 10.1016/j.surg.2014.08.068. Epub 2014 Nov 11.

PMID:
25456929
24.

A standardized and reproducible urine preparation protocol for cancer biomarkers discovery.

Beretov J, Wasinger VC, Schwartz P, Graham PH, Li Y.

Biomark Cancer. 2014 Nov 3;6:21-7. doi: 10.4137/BIC.S17991. eCollection 2014.

25.

PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.

Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y.

Cell Death Dis. 2014 Oct 2;5:e1437. doi: 10.1038/cddis.2014.415.

26.

Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.

Szczesniak MM, Maclean J, Zhang T, Graham PH, Cook IJ.

Clin Oncol (R Coll Radiol). 2014 Nov;26(11):697-703. doi: 10.1016/j.clon.2014.08.009. Epub 2014 Sep 16.

PMID:
25239671
27.

Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.

Browne LH, Graham PH.

Clin Trials. 2014 Dec;11(6):629-34. doi: 10.1177/1740774514542620. Epub 2014 Jul 14.

PMID:
25023199
28.

Proteomics for breast cancer urine biomarkers.

Beretov J, Wasinger VC, Graham PH, Millar EK, Kearsley JH, Li Y.

Adv Clin Chem. 2014;63:123-67. Review.

PMID:
24783353
29.

Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation.

Liu J, Hau E, Links M, Graham PH.

Asia Pac J Clin Oncol. 2016 Jun;12(2):e352-e355. doi: 10.1111/ajco.12184. Epub 2014 Mar 27.

PMID:
24673873
30.
31.

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.

Ni J, Cozzi PJ, Hao JL, Beretov J, Chang L, Duan W, Shigdar S, Delprado WJ, Graham PH, Bucci J, Kearsley JH, Li Y.

Prostate. 2014 May;74(6):602-17. doi: 10.1002/pros.22775. Epub 2014 Feb 12.

PMID:
24615685
32.

Breast irradiation causes pallor in the nipple-areolar complex in women with Celtic skin type (result from the St. George and Wollongong randomised breast boost trial).

Lee YY, Hau E, Browne LH, Chin Y, Lee J, Szwajcer A, Cail S, Nolan DN, Graham PH.

J Med Imaging Radiat Oncol. 2014 Apr;58(2):229-36. doi: 10.1111/1754-9485.12136. Epub 2014 Jan 24.

PMID:
24456128
33.

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.

Chang L, Graham PH, Hao J, Bucci J, Cozzi PJ, Kearsley JH, Li Y.

Cancer Metastasis Rev. 2014 Sep;33(2-3):469-96. doi: 10.1007/s10555-014-9493-5. Review.

PMID:
24445654
34.

Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.

Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y.

Cell Death Dis. 2013 Oct 24;4:e875. doi: 10.1038/cddis.2013.407.

35.

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells.

Xiao W, Graham PH, Hao J, Chang L, Ni J, Power CA, Dong Q, Kearsley JH, Li Y.

PLoS One. 2013 Aug 26;8(8):e74253. doi: 10.1371/journal.pone.0074253. eCollection 2013.

36.

Novel Rhizobium lineages isolated from root nodules of the common bean (Phaseolus vulgaris L.) in Andean and Mesoamerican areas.

Ribeiro RA, Ormeño-Orrillo E, Dall'Agnol RF, Graham PH, Martinez-Romero E, Hungria M.

Res Microbiol. 2013 Sep;164(7):740-8. doi: 10.1016/j.resmic.2013.05.002. Epub 2013 Jun 11.

PMID:
23764913
37.

The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial.

Hau E, Browne L, Capp A, Delaney GP, Fox C, Kearsley JH, Millar E, Nasser EH, Papadatos G, Graham PH.

Breast Cancer Res Treat. 2013 May;139(1):115-23. doi: 10.1007/s10549-013-2508-z. Epub 2013 Apr 12.

PMID:
23580069
38.

A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01.

Graham PH, Plant N, Graham JL, Browne L, Borg M, Capp A, Delaney GP, Harvey J, Kenny L, Francis M, Zissiadis Y.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):45-50. doi: 10.1016/j.ijrobp.2012.12.009. Epub 2013 Feb 12.

PMID:
23414763
39.

The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05).

Ball DL, Fisher RJ, Burmeister BH, Poulsen MG, Graham PH, Penniment MG, Vinod SK, Krawitz HE, Joseph DJ, Wheeler GC, McClure BE.

Radiother Oncol. 2013 Mar;106(3):305-11. doi: 10.1016/j.radonc.2012.12.003. Epub 2013 Jan 16.

PMID:
23333017
40.

Tear fluid protein biomarkers.

You J, Willcox MD, Madigan MC, Wasinger V, Schiller B, Walsh BJ, Graham PH, Kearsley JH, Li Y.

Adv Clin Chem. 2013;62:151-96.

PMID:
24772667
41.

Metastatic Cutaneous Squamous Cell Carcinoma to the Axilla: A Review of Patient Outcomes and Implications for Future Practice.

Beydoun N, Graham PH, Browne L.

World J Oncol. 2012 Oct;3(5):217-226. doi: 10.4021/wjon503w. Epub 2012 Oct 28.

42.

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.

Chao H, Wang L, Hao J, Ni J, Chang L, Graham PH, Kearsley JH, Li Y.

Cancer Lett. 2013 Feb 1;329(1):17-26. doi: 10.1016/j.canlet.2012.08.035. Epub 2012 Sep 18.

PMID:
22995071
43.

Digital photography as source documentation of skin toxicity: an analysis from the Trans Tasman Radiation Oncology Group (TROG) 04.01 post-mastectomy radiation skin care trial.

Graham PH, Plant NA, Graham JL, Browne LH, Borg M, Capp A, Delaney GP, Harvey J, Kenny L, Francis M, Zissiadis Y.

J Med Imaging Radiat Oncol. 2012 Aug;56(4):458-63. doi: 10.1111/j.1754-9485.2012.02365.x. Epub 2012 May 25.

PMID:
22883656
44.

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.

Hao J, Madigan MC, Khatri A, Power CA, Hung TT, Beretov J, Chang L, Xiao W, Cozzi PJ, Graham PH, Kearsley JH, Li Y.

PLoS One. 2012;7(8):e40716. doi: 10.1371/journal.pone.0040716. Epub 2012 Aug 3.

45.

Role of the EpCAM (CD326) in prostate cancer metastasis and progression.

Ni J, Cozzi PJ, Duan W, Shigdar S, Graham PH, John KH, Li Y.

Cancer Metastasis Rev. 2012 Dec;31(3-4):779-91. doi: 10.1007/s10555-012-9389-1. Review.

PMID:
22718399
46.

Metastatic cutaneous squamous cell carcinoma to parotid nodes: the role of bolus with adjuvant radiotherapy.

Pramana A, Browne L, Graham PH.

J Med Imaging Radiat Oncol. 2012 Feb;56(1):100-8. doi: 10.1111/j.1754-9485.2011.02326.x.

PMID:
22339753
47.

CD44 is a biomarker associated with human prostate cancer radiation sensitivity.

Xiao W, Graham PH, Power CA, Hao J, Kearsley JH, Li Y.

Clin Exp Metastasis. 2012 Jan;29(1):1-9. doi: 10.1007/s10585-011-9423-7. Epub 2011 Sep 28.

PMID:
21953074
48.

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.

Millar EK, Graham PH, McNeil CM, Browne L, O'Toole SA, Boulghourjian A, Kearsley JH, Papadatos G, Delaney G, Fox C, Nasser E, Capp A, Sutherland RL.

Br J Cancer. 2011 Jul 12;105(2):272-80. doi: 10.1038/bjc.2011.228. Epub 2011 Jun 28.

49.

Radiotherapy breast boost with reduced whole-breast dose is associated with improved cosmesis: the results of a comprehensive assessment from the St. George and Wollongong randomized breast boost trial.

Hau E, Browne LH, Khanna S, Cail S, Cert G, Chin Y, Clark C, Inder S, Szwajcer A, Graham PH.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):682-9. doi: 10.1016/j.ijrobp.2010.11.025. Epub 2011 Jan 20.

PMID:
21255943
50.

RE: faculty of radiation oncology endorsed guidelines for informed consent: risk description.

Graham PH.

J Med Imaging Radiat Oncol. 2010 Oct;54(5):512. doi: 10.1111/j.1754-9485.2010.02205.x. No abstract available.

PMID:
20958952

Supplemental Content

Loading ...
Support Center